Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Semjonow

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
International Journal of Molecular Sciences|June 6, 2013
Genome-wide investigation of multifocal and unifocal prostate cancer-are they genetically different?Chinyere Ibeawuchi, Hartmut Schmidt, Reinhard Voss, et al.
European Urology|April 23, 2003
Semi-quantitative immunochromatographic test for prostate specific antigen in whole blood: tossing the coin to predict prostate cancer?Frank Oberpenning, Stefan Hetzel, Christoph Weining, et al.
Prostate Cancer|July 6, 2019
The Association of the Long Prostate Cancer Expressed PDE4D Transcripts to Poor Patient Outcome Depends on the Tumour's TMPRSS2-ERG Fusion StatusDianne van Strijp, Christiane de Witz, Birthe Heitkötter, et al.
International Journal of Cancer|September 29, 2018
Somatic aberrations of BRCA1 gene are associated with ALDH1, EGFR, and tumor progression in prostate cancerAleksandra Omari, Paulina Nastały, Sara Stoupiec, et al.
The Journal of Urology|September 23, 2003
A multicenter clinical trial on the use of complexed prostate specific antigen in low prostate specific antigen concentrationsMichael Lein, Maciej Kwiatkowski, Axel Semjonow, et al.
European Urology Focus|July 21, 2017
Comparison of Two Prostate Cancer Risk Calculators that Include the Prostate Health IndexMonique J Roobol, Moniek M Vedder, Daan Nieboer, et al.
JCO Clinical Cancer Informatics|September 29, 2023
Efficient Augmented Intelligence Framework for Bladder Lesion DetectionOkyaz Eminaga, Timothy Jiyong Lee, Mark Laurie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2010
BRCA1 loss preexisting in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral bloodNatalia Bednarz, Elke Eltze, Axel Semjonow, et al.
Clinical Chemistry|June 18, 2005
Biological variation of total prostate-specific antigen: a survey of published estimates and consequences for clinical practiceGyörgy Sölétormos, Axel Semjonow, Paul E C Sibley, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2011
Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancerGholamreza Tavoosidana, Gunnar Ronquist, Spyros Darmanis, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
International Journal of Molecular Sciences|June 6, 2013
Genome-wide investigation of multifocal and unifocal prostate cancer-are they genetically different?Chinyere Ibeawuchi, Hartmut Schmidt, Reinhard Voss, et al.
European Urology|April 23, 2003
Semi-quantitative immunochromatographic test for prostate specific antigen in whole blood: tossing the coin to predict prostate cancer?Frank Oberpenning, Stefan Hetzel, Christoph Weining, et al.
Prostate Cancer|July 6, 2019
The Association of the Long Prostate Cancer Expressed PDE4D Transcripts to Poor Patient Outcome Depends on the Tumour's TMPRSS2-ERG Fusion StatusDianne van Strijp, Christiane de Witz, Birthe Heitkötter, et al.
International Journal of Cancer|September 29, 2018
Somatic aberrations of BRCA1 gene are associated with ALDH1, EGFR, and tumor progression in prostate cancerAleksandra Omari, Paulina Nastały, Sara Stoupiec, et al.
The Journal of Urology|September 23, 2003
A multicenter clinical trial on the use of complexed prostate specific antigen in low prostate specific antigen concentrationsMichael Lein, Maciej Kwiatkowski, Axel Semjonow, et al.
European Urology Focus|July 21, 2017
Comparison of Two Prostate Cancer Risk Calculators that Include the Prostate Health IndexMonique J Roobol, Moniek M Vedder, Daan Nieboer, et al.
JCO Clinical Cancer Informatics|September 29, 2023
Efficient Augmented Intelligence Framework for Bladder Lesion DetectionOkyaz Eminaga, Timothy Jiyong Lee, Mark Laurie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2010
BRCA1 loss preexisting in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral bloodNatalia Bednarz, Elke Eltze, Axel Semjonow, et al.
Clinical Chemistry|June 18, 2005
Biological variation of total prostate-specific antigen: a survey of published estimates and consequences for clinical practiceGyörgy Sölétormos, Axel Semjonow, Paul E C Sibley, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2011
Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancerGholamreza Tavoosidana, Gunnar Ronquist, Spyros Darmanis, et al.
Pageof 11